位置:首页 > 蛋白库 > PRDM6_HUMAN
PRDM6_HUMAN
ID   PRDM6_HUMAN             Reviewed;         595 AA.
AC   Q9NQX0; B5MCJ4; Q9NQW9;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   03-AUG-2022, entry version 175.
DE   RecName: Full=Putative histone-lysine N-methyltransferase PRDM6;
DE            EC=2.1.1.361 {ECO:0000250|UniProtKB:Q3UZD5};
DE   AltName: Full=PR domain zinc finger protein 6;
DE   AltName: Full=PR domain-containing protein 6;
GN   Name=PRDM6; Synonyms=PFM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=10668202; DOI=10.14670/hh-15.109;
RA   Jiang G.L., Huang S.;
RT   "The yin-yang of PR-domain family genes in tumorigenesis.";
RL   Histol. Histopathol. 15:109-117(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3]
RP   INVOLVEMENT IN PDA3, AND VARIANTS PDA3 SER-263; ARG-462 AND GLN-549.
RX   PubMed=27181681; DOI=10.1016/j.ajhg.2016.03.022;
RA   Li N., Subrahmanyan L., Smith E., Yu X., Zaidi S., Choi M., Mane S.,
RA   Nelson-Williams C., Bahjati M., Kazemi M., Hashemi M., Fathzadeh M.,
RA   Narayanan A., Tian L., Montazeri F., Mani M., Begleiter M.L., Coon B.G.,
RA   Lynch H.T., Olson E.N., Zhao H., Ruland J., Lifton R.P., Mani A.;
RT   "Mutations in the histone modifier PRDM6 are associated with isolated
RT   nonsyndromic patent ductus arteriosus.";
RL   Am. J. Hum. Genet. 98:1082-1091(2016).
CC   -!- FUNCTION: Putative histone methyltransferase that acts as a
CC       transcriptional repressor of smooth muscle gene expression. Promotes
CC       the transition from differentiated to proliferative smooth muscle by
CC       suppressing differentiation and maintaining the proliferative potential
CC       of vascular smooth muscle cells. Also plays a role in endothelial cells
CC       by inhibiting endothelial cell proliferation, survival and
CC       differentiation. It is unclear whether it has histone methyltransferase
CC       activity in vivo. According to some authors, it does not act as a
CC       histone methyltransferase by itself and represses transcription by
CC       recruiting EHMT2/G9a. According to others, it possesses histone
CC       methyltransferase activity when associated with other proteins and
CC       specifically methylates 'Lys-20' of histone H4 in vitro. 'Lys-20'
CC       methylation represents a specific tag for epigenetic transcriptional
CC       repression. {ECO:0000250|UniProtKB:Q3UZD5}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(20)-[histone H4] + S-adenosyl-L-methionine = H(+) +
CC         N(6)-methyl-L-lysyl(20)-[histone H4] + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:60344, Rhea:RHEA-COMP:15554, Rhea:RHEA-COMP:15555,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929; EC=2.1.1.361;
CC         Evidence={ECO:0000250|UniProtKB:Q3UZD5};
CC   -!- SUBUNIT: Interacts with HDAC1, HDAC2, HDAC3, CBX1 and EP300.
CC       {ECO:0000250|UniProtKB:Q3UZD5}.
CC   -!- INTERACTION:
CC       Q9NQX0; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-11320284, EBI-11096309;
CC       Q9NQX0; P21549: AGXT; NbExp=3; IntAct=EBI-11320284, EBI-727098;
CC       Q9NQX0; O43865: AHCYL1; NbExp=3; IntAct=EBI-11320284, EBI-2371423;
CC       Q9NQX0; Q49AR9: ANKS1A; NbExp=3; IntAct=EBI-11320284, EBI-11954519;
CC       Q9NQX0; P29972: AQP1; NbExp=3; IntAct=EBI-11320284, EBI-745213;
CC       Q9NQX0; Q03989: ARID5A; NbExp=3; IntAct=EBI-11320284, EBI-948603;
CC       Q9NQX0; Q8N5M1: ATPAF2; NbExp=3; IntAct=EBI-11320284, EBI-1166928;
CC       Q9NQX0; O95817: BAG3; NbExp=3; IntAct=EBI-11320284, EBI-747185;
CC       Q9NQX0; Q9H503-2: BANF2; NbExp=3; IntAct=EBI-11320284, EBI-11977289;
CC       Q9NQX0; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-11320284, EBI-11524452;
CC       Q9NQX0; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-11320284, EBI-8643161;
CC       Q9NQX0; O43439-4: CBFA2T2; NbExp=3; IntAct=EBI-11320284, EBI-11954144;
CC       Q9NQX0; Q9HC52: CBX8; NbExp=3; IntAct=EBI-11320284, EBI-712912;
CC       Q9NQX0; Q96HB5: CCDC120; NbExp=3; IntAct=EBI-11320284, EBI-744556;
CC       Q9NQX0; Q2TAC2-2: CCDC57; NbExp=3; IntAct=EBI-11320284, EBI-10961624;
CC       Q9NQX0; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-11320284, EBI-10175300;
CC       Q9NQX0; Q9UK58: CCNL1; NbExp=3; IntAct=EBI-11320284, EBI-2836773;
CC       Q9NQX0; Q8IYX8: CEP57L1; NbExp=3; IntAct=EBI-11320284, EBI-1104570;
CC       Q9NQX0; P10606: COX5B; NbExp=3; IntAct=EBI-11320284, EBI-1053725;
CC       Q9NQX0; P33240: CSTF2; NbExp=3; IntAct=EBI-11320284, EBI-711360;
CC       Q9NQX0; Q14241: ELOA; NbExp=3; IntAct=EBI-11320284, EBI-742350;
CC       Q9NQX0; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-11320284, EBI-744099;
CC       Q9NQX0; Q9NQT4: EXOSC5; NbExp=3; IntAct=EBI-11320284, EBI-371876;
CC       Q9NQX0; Q7L5A3: FAM214B; NbExp=3; IntAct=EBI-11320284, EBI-745689;
CC       Q9NQX0; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-11320284, EBI-6658203;
CC       Q9NQX0; Q14192: FHL2; NbExp=3; IntAct=EBI-11320284, EBI-701903;
CC       Q9NQX0; Q9NU39: FOXD4L1; NbExp=3; IntAct=EBI-11320284, EBI-11320806;
CC       Q9NQX0; O43559: FRS3; NbExp=3; IntAct=EBI-11320284, EBI-725515;
CC       Q9NQX0; Q9C0B1-2: FTO; NbExp=3; IntAct=EBI-11320284, EBI-18138793;
CC       Q9NQX0; Q8TAE8: GADD45GIP1; NbExp=3; IntAct=EBI-11320284, EBI-372506;
CC       Q9NQX0; P55040: GEM; NbExp=3; IntAct=EBI-11320284, EBI-744104;
CC       Q9NQX0; O95872: GPANK1; NbExp=3; IntAct=EBI-11320284, EBI-751540;
CC       Q9NQX0; A8MXD5: GRXCR1; NbExp=3; IntAct=EBI-11320284, EBI-5235612;
CC       Q9NQX0; P31273: HOXC8; NbExp=3; IntAct=EBI-11320284, EBI-1752118;
CC       Q9NQX0; Q14005-2: IL16; NbExp=3; IntAct=EBI-11320284, EBI-17178971;
CC       Q9NQX0; Q8NA54: IQUB; NbExp=3; IntAct=EBI-11320284, EBI-10220600;
CC       Q9NQX0; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-11320284, EBI-2556193;
CC       Q9NQX0; Q92993: KAT5; NbExp=3; IntAct=EBI-11320284, EBI-399080;
CC       Q9NQX0; Q7L273: KCTD9; NbExp=3; IntAct=EBI-11320284, EBI-4397613;
CC       Q9NQX0; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-11320284, EBI-14069005;
CC       Q9NQX0; P25800: LMO1; NbExp=3; IntAct=EBI-11320284, EBI-8639312;
CC       Q9NQX0; P25791-3: LMO2; NbExp=3; IntAct=EBI-11320284, EBI-11959475;
CC       Q9NQX0; Q17RB8: LONRF1; NbExp=3; IntAct=EBI-11320284, EBI-2341787;
CC       Q9NQX0; Q8TDC0: MYOZ3; NbExp=3; IntAct=EBI-11320284, EBI-5662487;
CC       Q9NQX0; O43639: NCK2; NbExp=3; IntAct=EBI-11320284, EBI-713635;
CC       Q9NQX0; Q9HC98-4: NEK6; NbExp=3; IntAct=EBI-11320284, EBI-11750983;
CC       Q9NQX0; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-11320284, EBI-10271199;
CC       Q9NQX0; Q9HBE1-4: PATZ1; NbExp=3; IntAct=EBI-11320284, EBI-11022007;
CC       Q9NQX0; Q8WWB5: PIH1D2; NbExp=3; IntAct=EBI-11320284, EBI-10232538;
CC       Q9NQX0; Q9NQX0: PRDM6; NbExp=3; IntAct=EBI-11320284, EBI-11320284;
CC       Q9NQX0; P54646: PRKAA2; NbExp=3; IntAct=EBI-11320284, EBI-1383852;
CC       Q9NQX0; Q13882: PTK6; NbExp=3; IntAct=EBI-11320284, EBI-1383632;
CC       Q9NQX0; P47897: QARS1; NbExp=3; IntAct=EBI-11320284, EBI-347462;
CC       Q9NQX0; O75771: RAD51D; NbExp=3; IntAct=EBI-11320284, EBI-1055693;
CC       Q9NQX0; Q9HAT0: ROPN1; NbExp=3; IntAct=EBI-11320284, EBI-1378139;
CC       Q9NQX0; Q06455-2: RUNX1T1; NbExp=3; IntAct=EBI-11320284, EBI-11984663;
CC       Q9NQX0; Q9UPU9-3: SAMD4A; NbExp=3; IntAct=EBI-11320284, EBI-11986417;
CC       Q9NQX0; O75716: STK16; NbExp=3; IntAct=EBI-11320284, EBI-749295;
CC       Q9NQX0; Q9Y4C2-2: TCAF1; NbExp=3; IntAct=EBI-11320284, EBI-11974855;
CC       Q9NQX0; Q8WW24: TEKT4; NbExp=3; IntAct=EBI-11320284, EBI-750487;
CC       Q9NQX0; Q08117-2: TLE5; NbExp=3; IntAct=EBI-11320284, EBI-11741437;
CC       Q9NQX0; Q14142: TRIM14; NbExp=3; IntAct=EBI-11320284, EBI-2820256;
CC       Q9NQX0; Q53H54: TRMT12; NbExp=3; IntAct=EBI-11320284, EBI-10242598;
CC       Q9NQX0; Q9BZW7: TSGA10; NbExp=3; IntAct=EBI-11320284, EBI-744794;
CC       Q9NQX0; Q3SY00: TSGA10IP; NbExp=3; IntAct=EBI-11320284, EBI-10241197;
CC       Q9NQX0; Q96PN8: TSSK3; NbExp=3; IntAct=EBI-11320284, EBI-3918381;
CC       Q9NQX0; Q5W5X9-3: TTC23; NbExp=3; IntAct=EBI-11320284, EBI-9090990;
CC       Q9NQX0; P57075-2: UBASH3A; NbExp=3; IntAct=EBI-11320284, EBI-7353612;
CC       Q9NQX0; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-11320284, EBI-11975223;
CC       Q9NQX0; Q68DK2-5: ZFYVE26; NbExp=3; IntAct=EBI-11320284, EBI-8656416;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q3UZD5}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NQX0-3; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=Q9NQX0-2; Sequence=VSP_036348, VSP_006929;
CC       Name=3; Synonyms=A;
CC         IsoId=Q9NQX0-1; Sequence=VSP_036348;
CC   -!- DISEASE: Patent ductus arteriosus 3 (PDA3) [MIM:617039]: A congenital
CC       heart defect characterized by the persistent opening of fetal ductus
CC       arteriosus that fails to close after birth. Fetal ductus arteriosus
CC       connects the pulmonary artery to the descending aorta, allowing
CC       unoxygenated blood to bypass the lung and flow to the placenta.
CC       Normally, the ductus occludes shortly after birth.
CC       {ECO:0000269|PubMed:27181681}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF78078.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAF78079.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF272898; AAF78078.1; ALT_INIT; mRNA.
DR   EMBL; AF272899; AAF78079.1; ALT_INIT; mRNA.
DR   EMBL; AC008548; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106786; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS47259.1; -. [Q9NQX0-3]
DR   RefSeq; NP_001129711.1; NM_001136239.1. [Q9NQX0-3]
DR   AlphaFoldDB; Q9NQX0; -.
DR   SMR; Q9NQX0; -.
DR   BioGRID; 125009; 82.
DR   IntAct; Q9NQX0; 72.
DR   MINT; Q9NQX0; -.
DR   STRING; 9606.ENSP00000384725; -.
DR   iPTMnet; Q9NQX0; -.
DR   PhosphoSitePlus; Q9NQX0; -.
DR   BioMuta; PRDM6; -.
DR   DMDM; 223590133; -.
DR   MassIVE; Q9NQX0; -.
DR   PaxDb; Q9NQX0; -.
DR   PeptideAtlas; Q9NQX0; -.
DR   PRIDE; Q9NQX0; -.
DR   ProteomicsDB; 82215; -. [Q9NQX0-3]
DR   ProteomicsDB; 82216; -. [Q9NQX0-1]
DR   Antibodypedia; 25663; 110 antibodies from 17 providers.
DR   DNASU; 93166; -.
DR   Ensembl; ENST00000407847.5; ENSP00000384725.3; ENSG00000061455.11. [Q9NQX0-3]
DR   GeneID; 93166; -.
DR   KEGG; hsa:93166; -.
DR   MANE-Select; ENST00000407847.5; ENSP00000384725.3; NM_001136239.4; NP_001129711.1.
DR   UCSC; uc003kti.4; human. [Q9NQX0-3]
DR   CTD; 93166; -.
DR   DisGeNET; 93166; -.
DR   GeneCards; PRDM6; -.
DR   HGNC; HGNC:9350; PRDM6.
DR   HPA; ENSG00000061455; Tissue enhanced (urinary).
DR   MalaCards; PRDM6; -.
DR   MIM; 616982; gene.
DR   MIM; 617039; phenotype.
DR   neXtProt; NX_Q9NQX0; -.
DR   OpenTargets; ENSG00000061455; -.
DR   Orphanet; 466729; Familial patent arterial duct.
DR   PharmGKB; PA33718; -.
DR   VEuPathDB; HostDB:ENSG00000061455; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; KOG2461; Eukaryota.
DR   GeneTree; ENSGT00940000155852; -.
DR   HOGENOM; CLU_032452_0_0_1; -.
DR   InParanoid; Q9NQX0; -.
DR   OMA; IGPFQGI; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; Q9NQX0; -.
DR   TreeFam; TF106403; -.
DR   BioCyc; MetaCyc:HS00755-MON; -.
DR   PathwayCommons; Q9NQX0; -.
DR   SignaLink; Q9NQX0; -.
DR   BioGRID-ORCS; 93166; 24 hits in 1096 CRISPR screens.
DR   GenomeRNAi; 93166; -.
DR   Pharos; Q9NQX0; Tbio.
DR   PRO; PR:Q9NQX0; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9NQX0; protein.
DR   Bgee; ENSG00000061455; Expressed in descending thoracic aorta and 123 other tissues.
DR   ExpressionAtlas; Q9NQX0; baseline and differential.
DR   Genevisible; Q9NQX0; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0042054; F:histone methyltransferase activity; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0051151; P:negative regulation of smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:ARUK-UCL.
DR   GO; GO:0022008; P:neurogenesis; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   CDD; cd19191; PR-SET_PRDM6; 1.
DR   Gene3D; 2.170.270.10; -; 1.
DR   InterPro; IPR044416; PRDM6_PR-SET.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR046341; SET_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00856; SET; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00317; SET; 1.
DR   SMART; SM00355; ZnF_C2H2; 4.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   SUPFAM; SSF82199; SSF82199; 1.
DR   PROSITE; PS50280; SET; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromatin regulator; Disease variant; Metal-binding;
KW   Methyltransferase; Nucleus; Reference proteome; Repeat; Repressor;
KW   S-adenosyl-L-methionine; Transcription; Transcription regulation;
KW   Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..595
FT                   /note="Putative histone-lysine N-methyltransferase PRDM6"
FT                   /id="PRO_0000047762"
FT   DOMAIN          246..365
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   ZN_FING         473..495
FT                   /note="C2H2-type 1; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         501..523
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         529..551
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         557..579
FT                   /note="C2H2-type 4; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          27..90
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        47..71
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        73..90
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..182
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10668202"
FT                   /id="VSP_036348"
FT   VAR_SEQ         314..595
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10668202"
FT                   /id="VSP_006929"
FT   VARIANT         263
FT                   /note="C -> S (in PDA3; unknown pathological significance;
FT                   dbSNP:rs879255279)"
FT                   /evidence="ECO:0000269|PubMed:27181681"
FT                   /id="VAR_077014"
FT   VARIANT         462
FT                   /note="Q -> R (in PDA3; dbSNP:rs879253872)"
FT                   /evidence="ECO:0000269|PubMed:27181681"
FT                   /id="VAR_077015"
FT   VARIANT         549
FT                   /note="R -> Q (in PDA3; dbSNP:rs879255278)"
FT                   /evidence="ECO:0000269|PubMed:27181681"
FT                   /id="VAR_077016"
SQ   SEQUENCE   595 AA;  64452 MW;  DB8D815E7C107451 CRC64;
     MLKPGDPGGS AFLKVDPAYL QHWQQLFPHG GAGPLKGSGA AGLLSAPQPL QPPPPPPPPE
     RAEPPPDSLR PRPASLSSAS STPASSSTSA SSASSCAAAA AAAALAGLSA LPVSQLPVFA
     PLAAAAVAAE PLPPKELCLG ATSGPGPVKC GGGGGGGGEG RGAPRFRCSA EELDYYLYGQ
     QRMEIIPLNQ HTSDPNNRCD MCADNRNGEC PMHGPLHSLR RLVGTSSAAA AAPPPELPEW
     LRDLPREVCL CTSTVPGLAY GICAAQRIQQ GTWIGPFQGV LLPPEKVQAG AVRNTQHLWE
     IYDQDGTLQH FIDGGEPSKS SWMRYIRCAR HCGEQNLTVV QYRSNIFYRA CIDIPRGTEL
     LVWYNDSYTS FFGIPLQCIA QDENLNVPST VMEAMCRQDA LQPFNKSSKL APTTQQRSVV
     FPQTPCSRNF SLLDKSGPIE SGFNQINVKN QRVLASPTST SQLHSEFSDW HLWKCGQCFK
     TFTQRILLQM HVCTQNPDRP YQCGHCSQSF SQPSELRNHV VTHSSDRPFK CGYCGRAFAG
     ATTLNNHIRT HTGEKPFKCE RCERSFTQAT QLSRHQRMPN ECKPITESPE SIEVD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024